Cumberland Pharmaceuticals Inc. Accounts Receivable
Cumberland Pharmaceuticals Inc. (CPIX) had Accounts Receivable of $13.42 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2026-08-07
- 2026-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $13.42M.
- 2026-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $14.26M.
- 2025-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $16.94M.
- 2025-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $10.43M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2026-06-30 | $13.42M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $14.26M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $16.94M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $10.43M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $10.32M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $10.49M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $11.70M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $11.31M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $11.62M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $10.65M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $9.76M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $12.62M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $12.22M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $14.53M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $13.16M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $15.23M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $13.28M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $14.64M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $6.88M 10-K · filed 2023-03-13 | |
| 2021-09-30 | $9.85M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $9.15M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $12.55M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $12.38M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $9.66M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $7.92M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $5.95M 10-Q · filed 2020-05-22 | |
| 2019-12-31 | $7.86M 10-K · filed 2021-03-12 | $9.78M 10-K · filed 2020-03-20 |
| 2019-09-30 | $8.30M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $8.43M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $9.97M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $6.46M 8-K · filed 2020-12-10 | $7.84M 10-K · filed 2019-03-12 |
| 2018-09-30 | $7.06M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $5.81M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $6.30M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $8.40M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $7.21M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $6.11M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $4.93M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $7.33M 10-K · filed 2018-03-09 | |
| 2016-09-30 | $6.67M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $4.55M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $4.82M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $6.08M 10-K · filed 2017-03-13 | |
| 2015-09-30 | $5.80M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $5.81M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $5.17M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $5.50M 10-K · filed 2016-03-14 | |
| 2014-09-30 | $5.30M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $6.01M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $5.42M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $4.53M 10-K · filed 2015-03-09 | |
| 2013-09-30 | $4.19M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $3.97M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $5.97M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $6.02M 10-K · filed 2014-03-11 | |
| 2012-09-30 | $5.47M 10-Q · filed 2012-11-02 | |
| 2012-06-30 | $4.99M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $4.46M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $7.08M 10-K · filed 2013-03-12 | |
| 2011-09-30 | $4.51M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $4.82M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $5.15M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |